National
Obama talks DOMA, bullying at Latino roundtable
POTUS says courts best path to bring DOMA to an end
Barack Obama (Washington Blade file photo by Michael Key)
President Obama said the courts represent the best path for bringing the Defense of Marriage Act to end in response to a question on what he’s doing to help bi-national same-sex couples stay together in the United States.
Gabriel Lerner, senior news editor for AOL Latino and Huff-Post Latino Voices, brought the question up on Thursday while moderating a roundtable called “Open for Questions with President Obama” on issues important to the Latino community:
—
Lerner: Mr. President, on the Defense of Marriage Act, also called DOMA, this comes from Kevin in North Carolina. He says: I’m a gay American who fell in love with a foreigner. As you know, due to DOMA, I’m not permitted to sponsor my foreign-born partner for residency. And as a result, we are stuck between a rock and an impossible situation. How do you intend to fix this? Waiting for DOMA to be repealed or struck down in the courts will potentially take years. What do binational couples do in the meantime?
Obama: Well, we made a decision that was a very significant decision, based on my assessment of the Constitution, that this administration would not defend DOMA in the federal courts. It’s not going to be years before this issue is settled. This is going to be settled fairly soon, because right now we have cases pending in the federal courts.
Administratively, we can’t ignore the law. DOMA is still on the books. What we have said is even as we enforce it, we don’t support it, we think it’s unconstitutional. The position that my administration has taken I think will have a significant influence on the court as it examines the constitutionality of this law. And once that law is struck down — and I don’t know what the ruling will be — then addressing these binational issues could flow from that decision, potentially.
I can’t comment on where the case is going to go. I can only say what I believe, and that is that DOMA doesn’t make sense; it’s unfair; I don’t think that it meets the demands of our Constitution. And in the meantime, if — I’ve already said that I’m also supportive of Congress repealing DOMA on it’s own and not waiting for the courts. The likelihood of us being able to get the votes in the House of Representatives for DOMA repeal are very low at this point so, truthfully, the recourse to the courts is probably going to be the best approach.
—
LGBT advocates working on immigration issues said in response to Obama’s comments that the president could do more to assist gay Americans in same-sex relationships with foreigners.
Lavi Soloway, founder of Stop the Deportations, said he doesn’t believe Obama’s answer was sufficient and the president should issue a moratorium to ensure foreign nationals in same-sex relationship aren’t deported because of DOMA:
“In his response, the President, a former constitutional law professor and son of a binational couple, said three times that DOMA is unconstitutional and affirmed his commitment to not to defend DOMA in court,” Soloway said. “Despite this, he believes that he must enforce this law against gay and lesbian Americans who are married to foreign nationals, until DOMA is repealed by Congress or struck down by the courts. The administration can and must do more to help binational couples now.”
Soloway continued, “First the administration must ensure that all binational couples are safe by issuing a moratorium on “DOMA deportations” and by issuing explicit written guidelines directing the exercise of prosecutorial discretion for same-sex binational couples.”
“Second, the administration must hold in abeyance decisions on all marriage-based green card applications filed by same-sex couples and stop denying those cases,” Soloway said. “This administration believes that it cannot approve such cases because of DOMA, but it does not follow that those cases must be denied. At the very least, we should wait until the fate of DOMA has been determined by Congress or the Supreme Court before decisions are rendered on any pending green card cases filed by lesbian and gay binational couples.”
Steve Ralls, spokesperson for Immigration Equality, also called on the administration can place the green card applications on hold for gay Americans seeking to sponsor their foreign partners for residency while still following the law:
“We obviously agree with the president that DOMA is unconstitutional,” Ralls said. “But we also know there are many things the president can do even before DOMA is repealed to help bi-national couples. The most significant among those is holding green card application filed by those couples until the courts have resolved DOMA’s fate. That gives legal protection to couples, it does not violate DOMA and it’s clearly within the president’s authority to do so. That should be the action that he takes until the courts intervene to end DOMA completely.”
Also during the roundtable, Obama discussed what his administration has done to combat the bullying of students, although the question was based on the bullying of students for being Latino as opposed to being LGBT.
Jose Siade, Yahoo’s editor in chief for U.S. Hispanic and Latin America, brought the question to the President during the roundtable:
—
Siade: This question comes from Florida: Since bullying is increasing in an alarming way in the U.S., what can be done to avoid further discrimination or bullying within various racial groups, particularly for Hispanic kids in school?
Obama: I think it’s a really important question. We actually had the first-ever conference on bullying here in the White House — because for young people it’s hard enough growing up without also then being subject to constant harassment. And the kind of bullying that we’re seeing now, including using the Internet and new media, can be very oppressive on young people.
So what we’ve tried to do is to provide information and tools to parents, to schools, to communities to push back and fight against these kinds of trends. And a lot of the best work has actually been done by young people themselves who start anti-bullying campaigns in their schools, showing how you have to respect everyone, regardless of race, regardless of religion, regardless of sexual orientation. And when you get a school environment in which that’s not accepted by young people themselves, where they say we’re not going to tolerate that kind of bullying, that usually ends up making the biggest difference, because kids react to their peer group more than sometimes they do adults.
And what we need to do is make sure that we’re providing tools to schools and to young people to help combat against bullying, and it’s something that we’ll continue to work on with local communities and local school districts as well.
Lerner: So you’re going to have a conference on bullying in the White House?
Obama: We already did. We had it — it was probably four or five months ago. And we brought in non-profit groups, religious leadership, schools, students themselves. And they have now organized conferences regionally, around the country, so that we can prevent this kind of bullying from taking place.
—
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Long-awaited ‘Pillion’ surpasses the sexy buzz
Reasons to be optimistic about 2026
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Using movement to boost your mental health during holidays
